サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404650

腫瘍アブレーションの市場規模、シェア、動向分析レポート：技術別、治療別、用途別、セグメント予測、2024年～2030年

Tumor Ablation Market Size, Share & Trends Analysis Report By Technology (Microwave, HIFU), By Treatment (Laparoscopic Ablation, Percutaneous Ablation), By Application (Liver Cancer, Lung Cancer), And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
腫瘍アブレーションの市場規模、シェア、動向分析レポート：技術別、治療別、用途別、セグメント予測、2024年～2030年
出版日: 2023年11月13日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腫瘍アブレーション市場の成長と動向：

Grand View Research社の最新レポートによると、世界の腫瘍アブレーション市場規模は2030年までに40億米ドルに達すると予測されています。

2024年から2030年までのCAGRは13.5%で拡大すると予測されています。がんの罹患率の増加と効果的な治療オプションに対する需要の高さが市場成長の主な要因です。国際がん研究機関によると、2020年には19,292,789人のがん患者が報告され、2025年には50,550,287人に達すると予測されています。乳がん、肺がん、大腸がん、前立腺がん、胃がんが最も多く報告されています。回復の早さ、患者の快適さ、所要時間の短さといった利点から、低侵襲手技への嗜好が高まっており、高度な腫瘍アブレーション手技の需要を牽引すると予測されています。

さらに、このような装置と超音波、MRI、CTのような非常に効果的なインターベンショナル・イメージング技術との統合は、外来で行われるアブレーション処置に変革をもたらすと考えられています。このシフトは、入院に関連する費用を含め、患者のコストを大幅に削減すると予想されます。検診プログラム、啓発キャンペーン、特定のがんスキームなどの政府主催のイニシアチブは、診断症例数を増加させると予測されます。例えば、2019年、英国の国民保健制度（NHS）は、特定の地域で肺がん検診プログラムを開始しました。このような取り組みにより、早期がん管理の需要が増加し、市場成長が促進されると予測されます。

腫瘍アブレーション市場レポートハイライト

  • ラジオ波アブレーション技術セグメントは、固形腫瘍除去への顕著な応用により、2023年に32.7%以上のシェアで市場をリードしました。
  • マイクロ波アブレーションセグメントは、2024年から2030年にかけて14.27%のCAGRで最速の成長が見込まれます。
  • 経皮的アブレーション治療セグメントは、2023年に約56.7％の最大の収益シェアを占めました。
  • 肺がん治療における腫瘍アブレーションは、2024年から2030年にかけて最も速い成長が見込まれています。座りがちなライフスタイル、喫煙率の増加、大気汚染の増加が肺がん有病率の増加に寄与しています。
  • 北米は、がん有病率の増加、購買力平価の高さ、質の高いヘルスケアに対する政府の支援、償還制度の利用可能性により、2023年の世界市場をリードしました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腫瘍アブレーション市場：変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
  • 腫瘍アブレーション市場分析ツール

第4章 腫瘍アブレーション市場：技術推定・動向分析

  • 定義と範囲
  • 技術市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 技術展望別の世界の腫瘍アブレーション市場
  • 市場規模、予測および動向分析、2018年から2030年まで

第5章 腫瘍アブレーション市場：治療推定・動向分析

  • 定義と範囲
  • 治療市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 治療別の世界の腫瘍アブレーション市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第6章 腫瘍アブレーション市場：用途推定・動向分析

  • 定義と範囲
  • 用途市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 用途別の世界の腫瘍アブレーション市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第7章 腫瘍アブレーション市場：地域推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 市場規模と予測トレンド分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合分析

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主要ディストリビューターとチャネルパートナーのリスト
    • 主要顧客
    • 主要企業市場シェア分析、2023年
    • Medtronic
    • Boston Scientific Corporation
    • Johnson &Johnson Service Inc.（Ethicon, Inc.）
    • AngioDynamics
    • Bioventus Inc.（Misonix Inc.）
    • EDAP TMS
    • Chongqing Haifu Medical Technology Co., Ltd
    • Mermaid Medical
    • HealthTronics, Inc.
    • HS Hospital Service SpA
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 U.S. tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 10 Canada tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 Canada tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 14 Europe tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 16 Europe tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 17 Germany tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 Germany tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 20 UK tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 UK tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 23 France tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 France tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 26 Italy tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 27Italy tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 28 Italy tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 29 Spain tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Spain tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 32 Denmark tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 Denmark tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 35 Sweden tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 37 Sweden tumor ablation market, by application,2018 - 2030 (USD Million)
  • Table 39 Norway tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Norway tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 41 Norway tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 46 China tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 47 China tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 48 China tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 49Japan tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Japan tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Japan tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 52 India tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 53 India tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 54 India tumor ablation market, by application2018 - 2030 (USD Million)
  • Table 55 South Korea tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 56 South Korea tumor ablation market, by treatment,2018 - 2030 (USD Million)
  • Table 57 South Korea tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 58 Australia tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Australia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 Australia tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Thailand tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 63 Thailand tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 66 Latin America surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 69Latin America tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Brazil tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 72 Brazil surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 73 Brazil laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 76 Mexico tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Mexico tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 78 Mexico surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 79 Mexico laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 80 Mexico percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 81 Mexico tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 82 Argentina tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Argentina tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 84 Argentina surgical ablation market, by application, 2018 - 2030 (USD Million)
  • Table 85 Argentina laparoscopic ablation market, by application, 2018 - 2030 (USD Million)
  • Table 86 Argentina percutaneous ablation market, by application, 2018 - 2030 (USD Million)
  • Table 87 Argentina tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 88 MEA tumor ablation market, by region, 2018 - 2030 (USD Million)
  • Table 89 MEA tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 90 MEA tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 91 MEA tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 92 South Africa tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 93 South Africa tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 94 South Africa tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 97 Saudi Arabia tumor ablation market, by application, 2018 - 2030 (USD Million)
  • Table 98 UAE tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 99 UAE tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 100 UAE tumor ablation market, by application,2018 - 2030 (USD Million)
  • Table 101 Kuwait tumor ablation market, by technology, 2018 - 2030 (USD Million)
  • Table 102 Kuwait tumor ablation market, by treatment, 2018 - 2030 (USD Million)
  • Table 103 Kuwait tumor ablation market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Tumor ablation market: market outlook
  • Fig. 14 Tumor ablation competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Tumor ablation market driver impact
  • Fig. 20 Tumor ablation market restraint impact
  • Fig. 21 Tumor ablation market strategic initiatives analysis
  • Fig. 22 Tumor ablation market: Technology movement analysis
  • Fig. 23 Tumor ablation market: Technology outlook and key takeaways
  • Fig. 24 Radiofrequency ablation market estimates and forecast, 2018 - 2030
  • Fig. 25 Microwave ablation estimates and forecast, 2018 - 2030
  • Fig. 26 Cryoablation market estimates and forecast, 2018 - 2030
  • Fig. 27 Irreversible electroporation ablation estimates and forecast, 2018 - 2030
  • Fig. 28 HIFU market estimates and forecast, 2018 - 2030
  • Fig. 29 Others estimates and forecast, 2018 - 2030
  • Fig. 30 Tumor ablation Market: Treatment Movement Analysis
  • Fig. 31 Tumor ablation market: Treatment outlook and key takeaways
  • Fig. 32 Surgical ablation market estimates and forecast, 2018 - 2030
  • Fig. 33 Percutaneous ablation market estimates and forecast,2018 - 2030
  • Fig. 34 Laparoscopic ablation market estimates and forecast,2018 - 2030
  • Fig. 35 Tumor ablation market: application movement analysis
  • Fig. 36 Tumor ablation market: application outlook and key takeaways
  • Fig. 37 Kidney cancer market estimates and forecast, 2018 - 2030
  • Fig. 38 Liver cancer market estimates and forecast,2018 - 2030
  • Fig. 39 Breast cancer market estimates and forecast, 2018 - 2030
  • Fig. 40 Lung cancer market estimates and forecast,2018 - 2030
  • Fig. 41 Prostate cancer market estimates and forecast, 2018 - 2030
  • Fig. 42 Other market estimates and forecast,2018 - 2030
  • Fig. 43 Global tumor ablation market: Regional movement analysis
  • Fig. 44 Global tumor ablation market: Regional outlook and key takeaways
  • Fig. 45 Global tumor ablation market share and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America, by country
  • Fig. 57 North America
  • Fig. 58 North America market estimates and forecast, 2018 - 2030
  • Fig. 59 U.S.
  • Fig. 60 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 61 Canada
  • Fig. 62 Canada market estimates and forecast, 2018 - 2030
  • Fig. 63 Europe
  • Fig. 64 Europe market estimates and forecast, 2018 - 2030
  • Fig. 65 UK
  • Fig. 66 UK market estimates and forecast, 2018 - 2030
  • Fig. 67 Germany
  • Fig. 68 Germany market estimates and forecast, 2018 - 2030
  • Fig. 69 France
  • Fig. 70 France market estimates and forecast, 2018 - 2030
  • Fig. 71 Italy
  • Fig. 72 Italy market estimates and forecast, 2018 - 2030
  • Fig. 73 Spain
  • Fig. 74 Spain market estimates and forecast, 2018 - 2030
  • Fig. 75 Denmark
  • Fig. 76 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 77 Sweden
  • Fig. 78 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 79 Norway
  • Fig. 80 Norway market estimates and forecast, 2018 - 2030
  • Fig. 81 Asia Pacific
  • Fig. 82 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 83 China
  • Fig. 84 China market estimates and forecast, 2018 - 2030
  • Fig. 85 Japan
  • Fig. 86 Japan market estimates and forecast, 2018 - 2030
  • Fig. 87 India
  • Fig. 88 India market estimates and forecast, 2018 - 2030
  • Fig. 89 Thailand
  • Fig. 90 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 91 South Korea
  • Fig. 92 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 93 Australia
  • Fig. 94 Australia market estimates and forecast, 2018 - 2030
  • Fig. 95 Latin America
  • Fig. 96 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 97 Brazil
  • Fig. 98 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 99 Mexico
  • Fig. 100 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 101 Argentina
  • Fig. 102 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 105 South Africa
  • Fig. 106 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 107 Saudi Arabia
  • Fig. 108 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecast, 2018 - 2030
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 113 Market share of key market players - Tumor ablation market
目次
Product Code: 978-1-68038-746-9

Tumor Ablation Market Growth & Trends:

The global tumor ablation market size is anticipated to reach USD 4.0 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 13.5% from 2024 to 2030. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

Tumor Ablation Market Report Highlights:

  • Radiofrequency ablation technology segment led the market with a share of more than 32.7% in 2023 owing to prominent application in solid tumor removal
  • Microwave ablation segment is expected to grow at the fastest CAGR of 14.27% from 2024 to 2030
  • The percutaneous ablation treatment segment held the largest revenue share of about 56.7% in 2023
  • Tumor ablation in lung cancer treatment is anticipated to witness the fastest growth from 2024 to 2030. Sedentary lifestyle, increasing incidences of smoking, and rising air pollution are contributing to the growing prevalence of lung cancer
  • North America led the global market in 2023 owing to increased prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Treatment
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tumor Ablation Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of cancer
      • 3.2.1.2. Technological advancements in ablation devices
      • 3.2.1.3. Increasing per capita income
      • 3.2.1.4. Growing demand of minimally invasive surgeries.
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
      • 3.2.2.2. Presence of alternative treatment options
  • 3.3. Tumor Ablation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Tumor Ablation Market: Technology Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Radiofrequency ablation
    • 4.1.2. Microwave ablation
    • 4.1.3. Cryoablation
    • 4.1.4. Irreversible electroporation ablation
    • 4.1.5. HIFU
    • 4.1.6. Other ablation technologies
  • 4.2. Technology Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Tumor Ablation Market by Technology Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Radiofrequency ablation
      • 4.5.1.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 4.5.2. Microwave Ablation
      • 4.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 4.5.3. Cryoablation
      • 4.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 4.5.4. Irreversible electroporation ablation
      • 4.5.4.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 4.5.5. HIFU
      • 4.5.5.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 4.5.6. Other ablation technologies
      • 4.5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Tumor Ablation Market: Treatment Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Surgical ablation
    • 5.1.2. Laparoscopic ablation
    • 5.1.3. Percutaneous ablation
  • 5.2. Treatment Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Tumor Ablation Market by Treatment Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Surgical Ablation
      • 5.5.1.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 5.5.2. Laparoscopic Ablation
      • 5.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 5.5.3. Percutaneous Ablation
      • 5.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)

Chapter 6. Tumor Ablation Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Kidney cancer
    • 6.1.2. Liver cancer
    • 6.1.3. Breast cancer
    • 6.1.4. Lung cancer
    • 6.1.5. Prostate cancer
    • 6.1.6. Other cancer
  • 6.2. Application Market Share, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Tumor Ablation Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Kidney cancer
      • 6.5.1.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
    • 6.5.2. Liver cancer
      • 6.5.2.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
    • 6.5.3. Breast cancer
      • 6.5.3.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
    • 6.5.4. Lung cancer
      • 6.5.4.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
    • 6.5.5. Prostate cancer
      • 6.5.5.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)
    • 6.5.6. Other cancer
      • 6.5.6.1. Market Size Estimates and Forecast 2018 to 2030 (USD Million)

Chapter 7. Tumor Ablation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. U.S. Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Canada Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. UK Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Germany Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. France Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Italy Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Spain Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Norway Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Sweden Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Denmark Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China Market Size Sstimates and Forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE Market Size Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait Market Size Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Medtronic
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Boston Scientific Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Johnson & Johnson Service Inc. (Ethicon, Inc.)
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. AngioDynamics
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Bioventus Inc. (Misonix Inc.)
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. EDAP TMS
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Chongqing Haifu Medical Technology Co., Ltd
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Mermaid Medical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. HealthTronics, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. H.S. Hospital Service S.p.A.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives